Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
Jennifer L. Yates, Dylan Ehrbar, Danielle Hunt, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100329-100329
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 227
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
Science Immunology (2022) Vol. 8, Iss. 79
Open Access | Times Cited: 172
Comparison of Seroconversion in Children and Adults With Mild COVID-19
Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e221313-e221313
Open Access | Times Cited: 85
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska I. L. Derksen, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 57
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine
Ana M. Espino, Albersy Armina-Rodríguez, Laura Alvarez, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 187-187
Open Access | Times Cited: 9
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Shilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
Ida Jarlhelt, Sif Kaas Nielsen, Camilla Xenia Holtermann Jahn, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women
Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 35
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
Christina Kober, Sandro Manni, Svenja Wolff, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262162-e0262162
Open Access | Times Cited: 35
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
Zoia R. Korobova, Е. В. Зуева, N. A. Аrsentieva, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 941-941
Open Access | Times Cited: 27
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
Marcus J. Bolton, Jefferson Santos, Claudia P. Arevalo, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 17
A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, Borrelia burgdorferi
Grace Freeman-Gallant, Kathleen A. McCarthy, Jennifer L. Yates, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 1, pp. 159-186
Closed Access
Differential Serotype Specificity in the IgG Subclass Profile of the Anti‐Domain III Response Elicited by Dengue Virus Infection
Luis Gabriel González‐Lodeiro, Pedro Henrique da Conceição Roque, Neyda Hernández, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Closed Access
Serum IgG4 level predicts COVID-19 related mortality
Emanuel Della‐Torre, Marco Lanzillotta, Marta Strollo, et al.
European Journal of Internal Medicine (2021) Vol. 93, pp. 107-109
Open Access | Times Cited: 32
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Amy B. Karger, James D. Brien, Jayne M. Christen, et al.
mSphere (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 23
Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development
Janet K. Yamamoto, Lekshmi K. Edison, Dawne K. Rowe-Haas, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 914-914
Open Access | Times Cited: 12
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
Devyani Joshi, Lindsay E. Nyhoff, Veronika I. Zarnitsyna, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107967-107967
Open Access | Times Cited: 12
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine.
Ana M. Espino, Albersy Armina-Rodríguez, Laura Alvarez, et al.
(2024)
Open Access | Times Cited: 4
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)
Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
(2024)
Open Access | Times Cited: 4
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)
Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 790-790
Open Access | Times Cited: 4
The kinetics of IgG subclasses and contributions to neutralizing activity against SARS‐CoV‐2 wild‐type strain and variants in healthy adults immunized with inactivated vaccine
Weixin Chen, Lichi Zhang, Juan Li, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 221-232
Open Access | Times Cited: 19
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104766-104766
Open Access | Times Cited: 19
Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study
David A. Lawrence, Aishwarya Jadhav, Tapan Kumar Mondal, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 950-950
Open Access | Times Cited: 3
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
Sasha E. Larsen, Bryan J. Berube, Tiffany Pecor, et al.
Journal of Immunological Methods (2021) Vol. 499, pp. 113160-113160
Open Access | Times Cited: 20
The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination
David Forgacs, Vanessa Silva‐Moraes, Giuseppe A. Sautto, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 696-696
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top